Alexandros Makriyannis in the news
Alexandros Makriyannis for Northeastern
New research by an interdisciplinary team, including Northeastern’s Alexandros Makriyannis, reveals how THC—the psychoactive ingredient in marijuana—gets into brain cells. The findings open the door to the development of new medications, free from side effects, for conditions from pain and obesity to neurological diseases and addiction.
Throughout Northeastern’s School of Pharmacy, researchers are making progress in solving a range of pressing health challenges.
New research from the Center for Drug Discovery at Northeastern presents a series of molecules that can be controllably deactivated, thereby reducing the side effects of potentially valuable drugs.